SCHEMBL5419974

SCHEMBL5419974

O=S(=O)(c1cccc(Cl)c1)N1CCC(N2COCc3cc(Br)ccc32)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MBTD1 Q05BQ5 1/20 0.47
L3MBTL3 Q96JM7 1/20 0.47
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HTR6 P50406 1/20 0.41
HPGD P15428 2/20 0.41
MAPT P10636 4/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
ADRB2 P07550 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CHRM4 P08173 1/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.38
PTPN11 Q06124 1/20 0.38
PKM P14618 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.37
CHRM1 P11229 1/20 0.37
DRD2 P14416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5421020 0.92 MBTD1 (0.53) MBTD1L3MBTL3ALDH1A1MEN1KMT2A
SCHEMBL5422773 0.92 ALDH1A1 (0.50) MBTD1L3MBTL3ALDH1A1MEN1KMT2A
SCHEMBL5434962 0.92 MBTD1 (0.57) MBTD1L3MBTL3ALDH1A1MEN1KMT2A
SCHEMBL5423710 0.89 ALDH1A1 (0.47) MBTD1L3MBTL3ALDH1A1MEN1KMT2A
SCHEMBL5422614 0.88 MBTD1 (0.47) MBTD1L3MBTL3ALDH1A1MEN1KMT2A
SCHEMBL5441500 0.88 MAPT (0.48) MBTD1L3MBTL3ALDH1A1MEN1KMT2A
SCHEMBL5430510 0.87 ALDH1A1 (0.45) MBTD1L3MBTL3ALDH1A1MEN1KMT2A
SCHEMBL5785791 0.87 ATM (0.41) MBTD1L3MBTL3MEN1KMT2AHPGD
SCHEMBL5428055 0.87 MBTD1 (0.43) MBTD1L3MBTL3ALDH1A1HPGDMAPT
SCHEMBL5785376 0.85 TSHR (0.44) ALDH1A1KMT2AHTR6HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070032482-A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2007-02-08 US claimed
US-20070032482-A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032482-A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments HTR6, HTR5A, P2RX6 MBTD1 1365/4885L3MBTL3 4883/4885ALDH1A1 1597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.